The Latest Cardiac and Vascular News
Results from expanded cohort of ongoing DELTA-HF study show patients were decongested with stable renal function and with few rehospitalizations at 90 days following treatment eLym System recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) February 13, 2025 08:50 AM Eastern Standard Time GALWAY, Ireland–(BUSINESS […]
GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in […]
With VP Clinical and VP Technical Operations, Company is Well Positioned for Next Phase of Growth GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering new ways to treat acute decompensated heart failure, announced today the appointment of Linda Nelson as Vice President of Clinical and Martin Keegan as Vice President of Technical […]
Adds to Portfolio of 40 Patents for Catheter-Based Technology That Leverages Power of Body’s Natural Fluid Removal Process GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering new ways to treat acute decompensated heart failure, announced today that the U.S. Patent and Trademark Office (USPTO) has granted the company a new patent for […]
GALWAY, Ireland–(BUSINESS WIRE)–WhiteSwell, a company pioneering new ways to treat acute decompensated heart failure, today announced the close of a $30 million series B funding round led by RA Capital Management and an InCube Ventures syndicate, with participation from other investors. Funds from the round will be used to support […]
